Viewing Study NCT02283294


Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2026-02-24 @ 5:08 AM
Study NCT ID: NCT02283294
Status: COMPLETED
Last Update Posted: 2021-11-30
First Post: 2014-10-29
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation
Sponsor: University of South Florida
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: PRO00019754
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View